IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $208,000 | -17.8% | 8,000 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $253,000 | -48.0% | 8,000 | -23.8% | 0.01% | -50.0% |
| Q4 2020 | $487,000 | +40.8% | 10,500 | 0.0% | 0.02% | +23.1% |
| Q3 2020 | $346,000 | +20.1% | 10,500 | 0.0% | 0.01% | +8.3% |
| Q2 2020 | $288,000 | -8.3% | 10,500 | 0.0% | 0.01% | -25.0% |
| Q1 2020 | $314,000 | +7.9% | 10,500 | 0.0% | 0.02% | +33.3% |
| Q4 2019 | $291,000 | +59.9% | 10,500 | +5.0% | 0.01% | +50.0% |
| Q3 2019 | $182,000 | -25.7% | 10,000 | 0.0% | 0.01% | -27.3% |
| Q2 2019 | $245,000 | +105.9% | 10,000 | -20.0% | 0.01% | +22.2% |
| Q1 2019 | $119,000 | +7.2% | 12,500 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $111,000 | -21.3% | 12,500 | 0.0% | 0.01% | -10.0% |
| Q3 2018 | $141,000 | -25.0% | 12,500 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $188,000 | -10.9% | 12,500 | 0.0% | 0.01% | -17.6% |
| Q1 2018 | $211,000 | +111.0% | 12,500 | 0.0% | 0.02% | +112.5% |
| Q4 2017 | $100,000 | +3.1% | 12,500 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $97,000 | +34.7% | 12,500 | 0.0% | 0.01% | +33.3% |
| Q2 2017 | $72,000 | – | 12,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |